Microalbuminuria in hemoglobinopathy patients who are taking Deferasirox
Background: Chelation therapy which is needed to prevent or reverse iron overload may also affect renal function in patients with hemoglobinopathy. The early indicator as well as predictor of nephropathy and glomerular damage among patients with sickle cell disease and thalassemia is microalbuminuri...
Main Authors: | Asaad A Khalaf, Zainab H Ahmed, Anwer Sh. Jaafar |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2015-01-01
|
Series: | Iraqi Journal of Hematology |
Subjects: | |
Online Access: | http://www.ijhonline.org/article.asp?issn=2072-8069;year=2015;volume=4;issue=2;spage=30;epage=44;aulast=Khalaf;type=0 |
Similar Items
-
Microalbuminuria en adolescentes obesos Microalbuminuria present in obese adolescents
by: Regino Piñeiro Lamas, et al.
Published: (2009-06-01) -
Iron overload and chelation therapy in hemoglobinopathies
by: Rayan Bou-Fakhredin, et al.
Published: (2018-04-01) -
Spectrum of hemoglobinopathies in a tertiary care centre
by: Nisha Sharma, et al.
Published: (2020-05-01) -
Diagnostic strategies in hemoglobinopathy testing, the role of a reference laboratory in the USA
by: Jennifer L. Oliveira
Published: (2018-04-01) -
NLR and microalbuminuria: Are these markers significantly associated?
by: Umeres-Francia, Gianfranco E., et al.
Published: (2018)